Webinar | March 10, 2023

Bioburden And The New EU GMP Annex 1: Risk Assessment, Reduction, And Testing

Contamination control strategies (CCS) were a hot topic in discussions leading up to the revision of EU GMP Annex 1, and some of the guideline’s principles can be applied where filtration is used for bioburden reduction of, for example, low-bioburden biological intermediates.

Experts on regulation, filtration, sampling and QC discuss risk assessment and filtration-based strategies to reduce bioburden.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online